Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Investing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Investing Activities ₹4,561 Cr₹-528 Cr₹-333 Cr₹-675 Cr₹-784 Cr

What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS is ₹4,561 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Investing Activities
Mar2024₹4,561 Cr
Mar2023₹-528 Cr
Mar2022₹-333 Cr
Mar2021₹-675 Cr
Mar2020₹-784 Cr

How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Investing Activities % Change
Mar2024 ₹4,561 Cr
Positive
Mar2023 ₹-528 Cr
Negative
Mar2022 ₹-333 Cr
Negative
Mar2021 ₹-675 Cr
Negative
Mar2020 ₹-784 Cr -

Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses